DS-7423

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDS-7423
Drug Alias NameDS-7423
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionmTOR Complex 2 inhibitorsPhosphatidylinositol 3 kinase alpha inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsMammalian target of Rapamycin (mTORC1)mTOR Complex 2Phosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursEndometrial NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A